A role of histaminergic neuronal systems in schizophrenia was suggested by an association with several polymorphisms located in the coding region of the histamine H 2 -receptor (H2R) gene (Orange et al, Mol Psychiatry 1996; 1: 466-469). Using either the reference method of direct sequencing or restriction endonuclease digestion of PCR products amplified from DNA, we could not confirm the existence of these polymorphisms in 53 Swedish controls, 52 French controls and 88 French schizophrenics. In contrast, we detected a G543A transition in the coding region of the gene that was not found in the British population. This allelic variation, which was observed in 15% of the controls with no homozygotes, did not change the amino acid sequence of the receptor. We also analyzed a 1.8-kb nucleotide sequence of the promoter region in which we detected two additional polymorphisms that may modulate the expression of the H2R gene. The first one was a A-592G transition located in the minimal promoter of the gene and found in ෂ10% of controls with no homozygotes. The second one was a G-1018A transition located in an enhancer element of the promoter and was found in ෂ20-30% of controls (with ෂ2-4% homozygotes). DNA analysis of the 88 French schizophrenic subjects revealed that the incidence of the three polymorphisms was not significantly different in this population. In conclusion, the present findings may suggest a surprisingly high variability of the H2R gene polymorphisms in different geographical areas but do not support an association of these allelic variations with schizophrenia. Molecular Psychiatry (2000) 5, 159-164.
Introduction
Histamine (HA) is a cerebral neurotransmitter released from neurons emanating from the posterior hypothalamus to project namely to limbic areas and affecting its target cells via activation of three receptor subtypes termed H 1 , H 2 , and H 3 . 1 The role of histaminergic systems in neuropsychiatric diseases remains unclear but several recent observations may suggest a relationship between HA and schizophrenia. In agreement, a recent study reported that levels of tele-methylhistamine, the major HA metabolite in brain, are enhanced in cerebrospinal fluid of schizophrenic patients, suggesting an increased activity of central HA neurons. 2 In contrast to 'typical' antipsychotics which tend to decrease HA neuron activity in vivo, 'atypical' neuroleptics markedly stimulate this activity, an effect that may underlie their therapeutic efficacy on negative symptoms of schizophrenia. 3 has also been observed in the frontal cortex of patients with schizophrenia. 4 In spite of the limited brain penetration of famotidine, a H2R antagonist, several openlabel clinical trials support an antipsychotic efficacy of this drug. [5] [6] [7] Recently, a polymorphism leading to an amino acid substitution within the third intracellular loop of the H2R was found to be associated with schizophrenia. 8, 9 We have further examined the presence of allelic variants in the coding and promoter regions of the H2R gene and investigated their putative association with schizophrenia.
Materials and methods

Human subjects
Samples were obtained from Swedish and French individuals. In the Swedish population, 53 individuals (33 males and 20 females) were recruited among 15 Swedish families with acute intermittent porphyria. All the individuals were interviewed by a psychiatrist using the survey module of the Swedish version of SCID-I to exclude psychiatric morbidity and were included as controls. In the French population, 52 unrelated con-trols (26 males and 26 females) were recruited mostly among the medical staff of the Centre Hospitalier Sainte-Anne in Paris. They were screened for no personal and/or familial psychiatric history with a semistandardized interview (SCID-NP). In order to analyze a putative association of H 2 R polymorphisms with schizophrenia, 88 unrelated patients with schizophrenia (55 males and 33 females) were recruited from a French Caucasian population among patients of the Centre Hospitalier Sainte-Anne. All patients fulfilled the DSM-III-R criteria for schizophrenia, as assessed with a semi-standardized interview (SADS-LA lifetime version anxiety version). All subjects but four (two controls and two patients) had at least three French Caucasian grandparents. Informed consent was obtained from all the individuals in the French and Swedish populations.
Polymerase chain reaction
Venous blood samples were collected in EDTA-lined tubes and DNA was extracted from peripheral leukocytes. 10 In order to analyze the promoter region and the coding region of the human H2R gene, 11, 12 five overlapping fragments (A-E) were amplified by PCR. Primers 1 and 2 (5Ј-AGGAGATTGCCTGCTCTCTGAA-3Ј, 5Ј-GA GACTCGTGAGAAAGAGTTGG-3Ј) were used to amplify fragment A corresponding to nucleotides −1772 to −738. Primers 3 and 4 (5Ј-TGTGGAGCTGAAAGT CTGTGTC-3Ј; 5Ј-AAAGGAAGAGGCTGTGCCATTG-3Ј) were used to amplify fragment B corresponding to nucleotides −820 to 30. Primers 5 and 6 (5Ј-GGCAT AGTTGTCACATTG-3Ј; 5Ј-ACACAAACGCGGTGAAGT-3Ј) were used to amplify fragment C corresponding to nucleotides −77 to 766. Primers 7 and 8 (5Ј-CAAT CATACCACCTCTAA-3Ј; 5Ј-TTACCTGTCTGTGGCT CC-3Ј) were used to amplify fragment D corresponding to nucleotides 501-1080. Primers 6 and 7 were also used to amplify fragment E. Genomic DNA (100 ng) was amplified in the following reaction mixture: 50 mM KCl, 10 mM Tris-HCl (pH 8.3), 1.5 mM MgCl 2 , 200 M of each deoxynucleotide triphosphate (dNTP), 0.4 M of each primer (Oligo Express, Paris, France) and 2.5 units Taq DNA polymerase (AmpliTaqGold, Perkin-Elmer, Roissy, France). After denaturation at 94°C for 9 min, DNA fragments (A-E) were amplified for 35 cycles with the following steps: 30 s at 94°C, 30 s at 64°C (A, B) or 58°C (C) or 56°C (D, E) and 30 s at 72°C. After the last cycle, the samples were incubated at 72°C for 8 min to complete the final extension.
Following amplification, the reaction mixture (5 l) was analyzed by gel electrophoresis to ensure correct amplification of each DNA fragment. Appropriate positive and negative controls were included.
Direct sequencing of PCR products
Allelic variations were first analyzed by direct sequencing of the previous PCR fragments amplified from genomic DNA of 20 (fragments A-D) or 60 (fragment E) French individuals. Each PCR product (25 l) was purified with the QIAquick PCR purification kit (Quiagen, Courtaboeuf, France) and one strand sequenced with the ABI PRISM DNA sequencing kit (Applied Biosystems, Roissy, France) using AmpliTaq DNA polymerase FS and the following specific IRD-800 dye labeled primers (MWG-Biotech, Courtaboeuf, France): primer 1 (5Ј-AAGGCTGGAAGTGCTTGTACTG-3Ј) corresponding to nucleotides −782 to −761 for fragment A, primer 2 (5Ј-TCTCAGTACAAGCACTTCCAGC-3Ј) corresponding to nucleotides −785 to −764 for fragment B, primer 3 (5Ј-ACCTTGAAGATGCGGTAG-3Ј) corresponding to nucleotides 606-623 for fragment C and primer 4 (5Ј-TTACCACCTCTAAGTGCAAAG-3Ј) corresponding to nucleotides 507-526 for fragments D and E. The labeled products were analysed after gel electrophoresis on a LI-COR 4000L automated DNA sequencing system.
Analysis of polymorphic restriction enzyme sites
Following amplification of fragment A, the PCR product (5 l) was digested overnight at 37°C by 2.5 units of Eae I restriction endonuclease and the appropriate reaction buffer. PCR products corresponding to DNA fragments B and E were cleaved in the same conditions by Afl III and Acc I restriction enzymes, respectively. Moreover, DNA fragment E was also analyzed by Taq I restriction endonuclease digestion as described. 8, 9 The restriction endonucleases used were from New England Biolabs (St Quentin en Yvelines, France). The products of each digestion were analyzed by separation on a 2% agarose gel and staining with ethidium bromide. Appropriate positive and negative controls were included. For each polymorphism, the restriction endonuclease digestion was performed for DNA genotyping of all the Swedish (n = 53), French (n = 52) controls and French schizophrenics (n = 88) and was carried out blind to the clinical status of the individuals.
Statistical analysis
Genotype distributions were first compared to predictable values from Hardy-Weinberg equilibrium. Twotailed comparisons of allele frequencies and genotype distributions were performed with 2 test except for 2 × 2 contingency tables for which Fisher exact test was used. 2 and P values were calculated using Instat for windows 95. In all cases, P values less than 0.05 were considered to be statistically significant.
Results
Detection of human H 2 receptor gene polymorphisms
Following amplification of DNA fragments A (nt −1772 to −738) and B (nt −820 to +30) from 20 French individuals and direct sequencing, a 1.8-kb 5Ј-upstream region located within the promoter of the gene was homologous to the previously reported sequence 12 except for a G to A transition that was observed at position −1018 and a A to G transition that was observed at position −592, in three cases respectively. The coding sequence of the H 2 receptor gene was the same as that previously reported 11 except for a G to A transition that was found in five cases at position 543 by direct sequencing of fragments C (nt −77 to 766) and D (nt 501-1080) amplified from DNA of 20 French subjects. The latter substitution was confirmed by sequencing of fragment E (nt 501-766) and was observed after amplification in nine French subjects out of 60. No other polymorphism could be observed in the coding region after direct sequencing of fragments C, D (n = 20) and E (n = 60).
Frequencies of human H 2 receptor gene polymorphisms in control and schizophrenic subjects
The allele frequencies and genotypes corresponding to the G-1018A, A-592G and G543A transitions that we have detected in the promoter and coding regions of the H 2 -receptor gene were analyzed by restriction endonuclease digestion. The corresponding PCR products were cleaved in a manner predicted by their sequence. After the G-1018A transition, an Eae I restriction site found within the original G-1018 sequence of fragment A was not maintained in the new A-1018 sequence (Figure 1 ). The Eae I cleavage patterns were used for genotyping of the Eae I polymorphism in Swedish (n = 53) and French (n = 52) controls. The allele A-1018 was found in only six Swedish families out of 15 (data not shown). The frequency of the A-1018 allele was rather high with a small proportion of homozygotes in both populations. No significant differences in the allele frequencies (Fisher exact test P = 0.10) and the distributions of the Eae I Table 1) . The genotype of French control and schizophrenic (n = 88) subjects was also compared by the same method. There were also no significant differences in the allele frequencies (Fisher exact test P = 0.89) and in the distribution of genotypes ( 2 = 0.13, df = 2, P = 0.94) between the two populations ( Table 1) .
The second polymorphism that we observed within the promoter region could be analysed by Afl III restriction endonuclease digestion of fragment B since an Afl III restriction site was introduced by the A-592G transition in the new G-592 sequence (Figure 2) . Afl III cleavage patterns of Swedish and French controls revealed a very low frequency of the G-592 allele (Table 2 ). There were no significant differences in the allele frequencies and genotype counts (Fisher exact test P = 0.75 and 0.74, respectively) between the two control populations. There were also no differences in the Afl III allele frequencies (Fisher exact test P = 0.51) and no differences in the distributions of Afl III genotypes ( 2 = 2.88, df = 2, P = 0.24) between French controls and schizophrenics ( Table 2) .
The genotype of control individuals and schizophrenic patients was also established for the polymorphism that we found in DNA fragments C, D and E at position 543 of the coding region. An Acc I restriction site was introduced by the G543A transition in the new A543 sequence of these fragments (Figure 3) . In both Swedish and French controls, the frequency of the A543 allele was low with no homozygotes (Table 3) . This Acc I allele was shown to be inherited in only three Swedish families (data not shown). No differences in the allele frequencies and the distributions of Acc I genotypes were revealed between the two control populations (Fisher exact test P = 1.00). There were also no significant differences of genotypes and allele frequencies between French controls and schizophrenics (Fisher exact test P = 0.81) ( Table 3) . These observed and expected values did not differ significantly.
The Taq I restriction site previously reported to be introduced by a A649G transition 8, 9 could not be found following digestion of the 266-bp fragment E. The two DNA fragments of 149 bp and 117 bp that were expected to be generated by this Taq I polymorphism were observed neither in the Swedish (n = 53) nor in the French (n = 140) individuals (data not shown).
Discussion
A recent study reported for the first time the existence of several polymorphisms in the H2R gene in a Caucasian UK population. 8 Direct sequencing of PCR fragments from five subjects first revealed three base substitutions at positions 649, 692 and 802 of the gene. Three additional transitions at positions 398, 525 and 620 were also found after sequencing of a cloned PCR product from one subject but were not confirmed by direct sequencing. The polymorphism observed at position 649 was an adenine/guanidine transition introducing a Taq I restriction site and leading to one amino acid substitution in the third intracellular loop of the receptor protein. By Taq I cleavage patterns and singlestranded conformational polymorphisms of PCR products, the same authors showed that this A649G transition occurred with a rather high frequency after analysis of two separate samples of 58 and 46 subjects respectively. 8, 9 Our present findings show that this allelic variant of the human H2R gene could not be identified in either French or Swedish populations using two different methods ie direct sequencing or Taq I restriction endonuclease digestion of PCR fragments applied to 60 and 193 subjects respectively. In addition, none of the other base substitutions mentioned above could be detected after direct sequencing of several PCR fragments amplified from 20-60 French individuals. This discrepancy clearly requires further investigation and should be confirmed by additional analysis of both British and French populations using the same methodological approach. If confirmed, it would therefore suggest a high variability of the genotypes of the H2R gene in different geographical areas. However, this appears rather unexpected if not unlikely and only a metaanalysis performed from a large number of samples with different origins would establish the impact of ethnic heterogeneity on genotype frequencies of the H2R gene.
On the other hand, we identified within the coding region of the gene, a G543A transition creating a Acc I polymorphism that was not reported in the UK population. 8 However, the corresponding new allelic variant did not change the amino acid sequence of the receptor and occurred with a low frequency both in the Swedish and French population.
We also identified two Eae I and Afl III polymorphisms at positions −592 and −1018 in the promoter region of the gene after direct sequencing and restriction analysis of PCR products from a 1.8-kb nucleotide sequence that was recently determined. 12 These polymorphisms were located in the minimal promoter and in an enhancer element of the gene, respectively and might therefore modulate the expression of the H2R gene.
An association of the A649G transition with schizophrenia was established by Orange et al after analysis of PCR products from 47 schizophrenic patients from the UK, with a 1.8 times higher incidence found for the Molecular Psychiatry new allele in this population. 9 However, the present findings suggest that this apparent association might be due to other factors such as ethnic heterogeneity. In agreement, no association with schizophrenia could be found with any of our three Acc I, Afl III and Eae I polymorphisms after restriction analysis of PCR products from 88 French schizophrenics.
In conclusion, the present findings obtained in a Swedish and French population, identify three H2R gene polymorphisms, different from those previously reported in a UK population, but do not support any association of these polymorphisms with schizophrenia.
